Erythromycin Tablets: recall status
⚠ Recalls found. Erythromycin Tablets is named in 2 official recalls in our current data:
- Brand
- Zydus Pharmaceuticals (USA)
Recalls naming this model
FDA Class II · Drug · May 27, 2026
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Company / brand: Zydus Pharmaceuticals (USA)
Affected product: Erythromycin Tablets
Official ID D-0544-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Company / brand: Zydus Pharmaceuticals (USA)
Affected product: Erythromycin Tablets
Official ID D-0545-2026 ·
Official record ↗
See all Zydus Pharmaceuticals (USA) recalls →
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.